PRKCD and atherosclerosis: Activation of monocytes/macrophages contributes to atherosclerosis, and the activation of the PKC-δ isoform in monocytes can decrease the number of monocytes and inflammatory responses in the arterial wall, thus slowing the development of atherosclerosis (143).